Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Shares Outstanding (Weighted Average): 2015-2024

Historic Shares Outstanding (Weighted Average) for Wave Life Sciences (WVE) over the last 10 years, with Dec 2024 value amounting to $152.5 million.

  • Wave Life Sciences' Shares Outstanding (Weighted Average) rose 27.58% to $159.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $159.1 million, marking a year-over-year increase of 27.58%. This contributed to the annual value of $152.5 million for FY2024, which is 53.98% up from last year.
  • Wave Life Sciences' Shares Outstanding (Weighted Average) amounted to $152.5 million in FY2024, which was up 53.98% from $99.1 million recorded in FY2023.
  • Wave Life Sciences' 5-year Shares Outstanding (Weighted Average) high stood at $152.5 million for FY2024, and its period low was $48.8 million during FY2020.
  • For the 3-year period, Wave Life Sciences' Shares Outstanding (Weighted Average) averaged around $112.8 million, with its median value being $99.1 million (2023).
  • Data for Wave Life Sciences' Shares Outstanding (Weighted Average) shows a peak YoY spiked of 53.98% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows Wave Life Sciences' Shares Outstanding (Weighted Average) stood at $48.8 million in 2020, then grew by 20.61% to $58.8 million in 2021, then skyrocketed by 47.71% to $86.9 million in 2022, then increased by 13.99% to $99.1 million in 2023, then surged by 53.98% to $152.5 million in 2024.